2m 2m 2m 2m 2m 2m 2m
- $11.7BMarket Cap
- -17.27%1-Year Change
- Medical Instruments & SuppliesIndustry
COOPER CO (COO)
Key Performance
More- Earnings Score: 55
- Momentum Score: 17
- True Yield: N/A
- Financial Health Score: 64
Latest Research & News
The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. following a 14.6% stock decline on September 10, 2026, after disappointing earnings guidance and a decision not to sell Cooper Surgical. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.
10/22/2026, 6:29 PM • GlobeNewswire
Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was prompted by Cooper Companies' disappointing earnings report on September 10, 2026, which included weak guidance and a decision not to sell Cooper Surgical, causing the stock to fall 14.6% that day. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.
10/19/2026, 8:23 PM • GlobeNewswire
Rosen Law Firm has launched an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following allegations of materially misleading business information. The investigation was prompted by Cooper Companies' September 10, 2026 earnings report that disappointed Wall Street with weak guidance and a decision not to sell Cooper Surgical, resulting in a 14.6% stock decline. The firm is preparing a class action lawsuit to recover investor losses on a contingency fee basis.
10/16/2026, 2:56 PM • GlobeNewswire
Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by directors and officers of Sprout Social, Inc. The firm is encouraging current shareholders to contact them regarding their rights. Rosen Law Firm is also investigating securities claims for The Cooper Companies, Inc. and has filed a class action lawsuit for Netcapital Inc. investors.
10/16/2026, 2:54 PM • GlobeNewswire
Cooper Companies director Paul Keel purchased 4,701 shares worth $250,000 at $53.18 per share on September 11, 2026, following a 21% year-long stock decline. The insider buy is viewed as a bullish signal, suggesting confidence in the company's long-term growth prospects. Keel, who recently joined Cooper's board in May, brings extensive experience from his CEO role at Envista Holdings and prior positions at 3M.
10/07/2026, 10:38 AM • The Motley Fool
Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was prompted by Cooper Companies' September 10, 2026 earnings report that disappointed Wall Street with weak guidance and a decision not to sell Cooper Surgical, causing the stock to fall 14.6% that day. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.
10/06/2026, 1:59 PM • GlobeNewswire
The Cooper Companies faces a securities fraud investigation following disappointing Q3 2026 results. The company reported flat year-over-year revenue of $717 million, attributed to U.S. channel inventory reductions. Cooper lowered full-year guidance by approximately 1.4% in revenue and 1.8% in EPS, causing shares to decline 14.67% on September 10, 2026.
10/05/2026, 11:00 AM • GlobeNewswire
Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.
10/02/2026, 1:11 PM • The Motley Fool
Rosen Law Firm has announced an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was triggered by CooperCompanies' disappointing earnings report on September 10, 2026, which included weak guidance and a decision not to sell CooperSurgical, causing the stock to fall 14.6%. Investors who purchased CooperCompanies securities may be eligible for compensation through a class action lawsuit.
09/25/2026, 9:05 PM • GlobeNewswire
Law firm Kirby McInerney LLP is investigating potential securities law violations by Cooper Companies following the company's September 9, 2026 earnings announcement. CooperCompanies reported Q3 revenue of $1.07 billion, missing analyst expectations of $1.10 billion, with its CooperVision segment showing flat year-over-year growth. The company attributed underperformance to proactive U.S. channel inventory reductions. The stock declined 14.7% on the news, falling from $63.48 to $54.17 per share.
09/15/2026, 3:33 PM • GlobeNewswire
The Cooper Companies' stock plummeted 14.6% on September 10, 2026, after Q3 2026 earnings revealed significant U.S. channel inventory destocking at its CooperVision segment. The company reduced full-year revenue guidance to flat or down 2% organically, attributing the decline entirely to inventory reductions. Hagens Berman has opened an investigation into whether Cooper was sufficiently transparent about its sales practices and potential securities law violations.
09/12/2026, 2:49 PM • GlobeNewswire
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yield; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow metrics.
02/18/2026, 12:24 PM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 11:08 AM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As market leadership shifts and investors rotate away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 7:38 AM • Investing
3 Undervalued Stocks to Buy in a Rotating Market
As the stock market rotates away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.
02/18/2026, 6:44 AM • Investing
Peers
Statistics
MoreInformation as of 10/22/2026
Company Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Key Executives
- Albert G. White
- Daniel G. McBride
- Brian G. Andrews
- Holly R. Sheffield
- Gerard H. Warner
Current Ownership Distribution
- Institutions2.3B (54.21%)
- Mutual Funds1.9B (45.75%)
- Insiders1.8M (0.04%)
- Other0 (0.00%)